KLOW Kit – GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg)
KLOW is a four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV to study tissue repair, inflammation control, and cellular regeneration in laboratory models.
$550.00
In Stock
Payment. Payment upon receipt of goods, Payment by card in the department, Google Pay, Online card, -5% discount in case of payment
Warranty. The Consumer Protection Act does not provide for the return of this product of proper quality.
Description
Description
KLOW is a four-peptide research blend combining GHK-Cu, BPC-157, TB-500, and KPV to study tissue repair, inflammation control, and cellular regeneration in laboratory models.
Composition and Purpose
The KLOW peptide blend contains GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg) in a single vial. It is intended for research use only and is not for human or veterinary consumption. Each peptide targets distinct biological pathways involved in repair and regeneration.
GHK-Cu
A copper-binding tripeptide that stimulates collagen and elastin production, promotes angiogenesis, enhances fibroblast proliferation, and modulates gene expression associated with tissue repair.
BPC-157
A gastric pentadecapeptide that supports tendon, ligament, and muscle repair, promotes angiogenesis, protects gut mucosa, and accelerates recovery from tissue injury.
TB-500
A synthetic fragment of thymosin beta-4 that regulates actin polymerization, enhances cell migration, and supports angiogenesis, facilitating tissue remodeling and wound closure.
KPV
A tripeptide fragment of alpha-melanocyte-stimulating hormone that inhibits NF-κB and MAPK pathways, offering potent anti-inflammatory effects and supporting barrier integrity in gut and skin models.
Mechanisms and Research Applications
KLOW is designed to explore synergistic effects across multiple biological pathways:
Tissue repair and remodeling: GHK-Cu and BPC-157 support extracellular matrix synthesis and enhance fibroblast activity.
Angiogenesis: BPC-157 and TB-500 promote the formation of new blood vessels, a critical component of healing.
Cell migration: TB-500 enhances actin-driven cell movement to sites of injury.
Inflammation control: KPV modulates immune signaling while preserving normal immune function.
This multi-pathway approach enables researchers to study systemic regenerative processes in vitro and in animal models, including wound healing, gut protection, and connective tissue repair.

![GLOW Kit [ GHK(65MG) + BPC(15MG) + TB(10MG) ] x 10](https://optiiusa.io/wp-content/uploads/2026/05/bb1a796353e454f3d52d-500x500.jpg)



Reviews
There are no reviews yet.